We are live on ! Find out more
GDRX icon

GoodRx Holdings

180 hedge funds and large institutions have $651M invested in GoodRx Holdings in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 46 increasing their positions, 55 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 34

3% more funds holding

Funds holding: 174180 (+6)

4% more call options, than puts

Call options by funds: $5.64M | Put options by funds: $5.44M

16% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 55

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

21.58% less ownership

Funds ownership: 186.97%165.4% (-22%)

29% less capital invested

Capital invested by funds: $916M → $651M (-$265M)

Holders
180
Holders Change
+6
Holders Change %
+3.45%
% of All Funds
3.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
40
Increased
46
Reduced
55
Closed
34
Calls
$5.64M
Puts
$5.44M
Net Calls
+$204K
Net Calls Change
+$274K
Name Holding Trade Value Shares
Change
Change in
Stake
FIA
151
FNY Investment Advisers
New York
$2K -$630 -100 -17%
AWM
152
Avondale Wealth Management
Texas
$2K
WWM
153
Wolff Wiese Magana
California
$2K
MGIM
154
M&G Investment Management
United Kingdom
$1.29K +$1.63M +258,561 New
LSA
155
Leonteq Securities AG
Switzerland
$1.05K -$4.86K -771 -77%
Northwestern Mutual Wealth Management
156
Northwestern Mutual Wealth Management
Wisconsin
$1K -$30.8K -4,879 -96%
CFD
157
Creative Financial Designs
Indiana
$1K -$1.89K -300 -50%
SPIA
158
Steward Partners Investment Advisory
New York
$1K -$441 -70 -33%
ARMC
159
American Research & Management Company
Massachusetts
$1K
CA
160
Clearstead Advisors
Ohio
$1K
CCA
161
Column Capital Advisors
Indiana
$1K
EA
162
Emerald Advisers
Pennsylvania
$1K
EW
163
Evoke Wealth
California
$1K
MWA
164
Moser Wealth Advisors
Washington
$1K
PA
165
Parallel Advisors
California
$1K
TSWM
166
Tyler-Stone Wealth Management
Ohio
$1K
APA
167
American Portfolios Advisors
New York
$593 -$7.88K -1,250 -91%
GH
168
GAM Holding
Switzerland
-$5.09M -859,370 Closed
Alyeska Investment Group
169
Alyeska Investment Group
Illinois
-$2.96M -500,000 Closed
ACM
170
AlphaCrest Capital Management
New York
-$1.88M -317,178 Closed
Capital Fund Management (CFM)
171
Capital Fund Management (CFM)
France
-$1.43M -240,808 Closed
Amundi
172
Amundi
France
-$1.14M -185,318 Closed
TAS
173
TIFF Advisory Services
Pennsylvania
-$868K -146,551 Closed
VI
174
Versor Investments
New York
-$698K -117,829 Closed
ASN
175
Advisory Services Network
Georgia
-$591K -99,827 Closed

GDRX Hedge Fund Activity: Q3 2022 in Review

180 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2022, worth a combined $651M — down 29% from $916M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new GDRX positions and 34 closed out — a net gain of 6 holders — while 46 added to existing stakes and 55 trimmed.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $9.12M. The largest seller was Morgan Stanley, cutting an estimated $111M.

  • 180 institutional investors held GoodRx Holdings (GDRX) as of Q3 2022, up from 174 in Q2 2022.
  • Funds reported $651M of GoodRx Holdings stock for Q3 2022, down 29% quarter-over-quarter.
  • 40 funds opened new GoodRx Holdings positions in Q3 2022 and 34 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $9.12M added.
  • The largest GoodRx Holdings seller in Q3 2022 was Morgan Stanley, an estimated $111M sold.

Based on aggregated 13F filings for Q3 2022.